
IIPR Stock Forecast & Price Target
IIPR Analyst Ratings
Bulls say
Innovative Ind Props is viewed favorably because its balance sheet is strong, with net-debt+preferred/EBITDA of 2.3x versus a 4.9x group average, about $142 million of cash and equivalents pro forma, and no debt maturities until 2028, giving it flexibility to manage capital and fund growth. The company is also improving portfolio quality after resolving multiple tenant issues, while a healthy lease profile with a 11.9-year WALT and 71.0% of ABR expiring after 2035 supports cash flow stability. Its pivot toward life science, including the IQHQ investments, should diversify revenue, improve tenant credit quality, and help support the 14.7% dividend yield and expected AFFO growth to $8.04 by 2028.
Bears say
Innovative Ind Props is viewed negatively because its cash flows remain highly exposed to cannabis-tenant distress, with defaults ramping since late 2022 and three additional defaults in 2026, while top-ten tenants still represent 75.0% of ABR as of June 30, 2026. Management’s backfilling of defaulted space is a near-term positive, but the lack of disclosed replacement rents and the specialized, slow-to-retenant nature of cannabis assets make the earnings run rate uncertain, especially after AFFO fell from $9.08 per share in 2023 to $7.24 in 2025. Concerns are amplified by the sizable IQHQ exposure, which represents about 30% of gross asset value and 26% of earnings, because estimated stabilized NOI of $110m appears insufficient against $160m to $240m of debt service.
This aggregate rating is based on analysts' research of Innovative Industrial Properties and is not a guaranteed prediction by Public.com or investment advice.
IIPR Analyst Forecast & Price Prediction
Start investing in IIPR
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Innovative Industrial Properties (IIPR) Forecast
IIPR Analyst Forecast & Price Prediction
Start investing in IIPR
Order type
Buy in
Order amount
Est. shares
0 shares